SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Securities Fraud Violat...
June 01 2016 - 11:08AM
Business Wire
Levi & Korsinsky announces it has commenced an investigation
of Osiris Therapeutics, Inc. (“Osiris Therapeutics” or the
“Company”) (NASDAQ: OSIR) concerning possible violations of federal
securities laws.
On May 27, 2016, Osiris disclosed in an SEC filing that it is
the subject of a criminal investigation by the U.S. Attorney’s
Office for the Southern District of New York. According to Osiris,
this investigation concerns matters similar to those already under
investigation by the SEC. Osiris has repeatedly delayed the filing
of its Form 10-Q for the quarter ended March 31, 2016 as it
undergoes an accounting review and audit of certain previous
financial statements. In addition, the Company is currently the
subject of a lawsuit filed by competitor MiMedx Group, Inc.
According to the complaint, Osiris allegedly released false and
misleading clinical data concerning one of its drug treatments. To
obtain additional information about the investigation, go
to:
http://zlk.9nl.com/osiris-therapeutics-osir
or contact Eduard Korsinsky, Esq. either via email at ek@zlk.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive expertise and experience
representing investors in securities litigation involving financial
fraud, and have recovered hundreds of millions of dollars for
aggrieved shareholders. Attorney advertising. Prior results do not
guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160601006335/en/
Levi & Korsinsky, LLPEduard Korsinsky, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Historical Stock Chart
From Apr 2023 to Apr 2024